Townsquare Capital LLC Galapagos Nv Transaction History

Townsquare Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$185.52 - $231.25 $197,393 - $246,050	-1,064 Reduced 39.9%	1,603 $306,000
Q1 2020 May 18, 2020	SELL	$143.0 - $274.03 $106,964 - $204,974	-748 Reduced 21.9%	2,667 $571,000
Q4 2019 May 18, 2020	BUY	$146.12 - $215.82 $4,821 - $7,122	33 Added 0.98%	3,415 $707,000
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $5,217 - $7,505	40 Added 1.2%	3,382 $622,000
Q2 2019 Aug 15, 2019	SELL	$111.45 - $128.93 $45,360 - $52,474	-407 Reduced 10.86%	3,342 $576,000
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $88,534 - $116,366	988 Added 35.78%	3,749 $442,000
Q4 2018 Feb 13, 2019	BUY	$87.81 - $110.65 $242,443 - $305,504	2,761 New	2,761 $279,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.